Search

Author/Creator Lorscheider, J.

1. Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study. (2nd November 2018)

Authors:
Lorscheider, J.; Kuhle, J.; Izquierdo, G.; Lugaresi, A.; Havrdova, E.; Horakova, D.; Hupperts, R.; Duquette, P.; Girard, M.; Prat, A.; Grand'Maison, F.; Grammond, P.; Sola, P.; Ferraro, D.; Trojano, M.; Ramo‐Tello, C.; Lechner‐Scott, J.; Pucci, E.; Solaro, C.; Slee, M.
Journal:
European journal of neurology
Issue:
Volume 26:Number 2(2019)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment. (3rd April 2020)

Authors:
von Wyl, V.; Décard, B. F.; Benkert, P.; Lorscheider, J.; Hänni, P.; Lienert, C.; Kuhle, J.; Derfuss, T.; Kappos, L.; Yaldizli, Ö.
Journal:
European journal of neurology
Issue:
Volume 27:Number 6(2020)
Page Start:
1066
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search